Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: J Clin Virol. 2023 Sep 12;168:105583. doi: 10.1016/j.jcv.2023.105583

Table 1.

Overview of examined samples, patients, and research question

Subject Sample type Viral load (IU/mL) Description Research question / challenge Background described in
1 CSF 6.15E+03 patient had encephalitis of unknown origin with atypical symptoms, HEV infection retrospectively identified through HTS Typing, Virus variant/mutation causative for CNS symptomatic? this study (study previously mentioned in [39])
2 FFPE sample from a liver biopsy ~1E+04* liver biopsy obtained after rejection of transplant, stored as FFPE mounted on a microscope slide for >5 years at room temperature Typing, Sequencing of HEV from a degraded FFPE sample stored under improper conditions Hillebrandt et al., unpublished
3 serum 4.18E+04 HEV detected in an Irish blood donation, subtyping through fragment sequencing failed Typing, New variant/genotype that caused subtyping to fail? [30]
4 serum 6,96E+03 HEV genotype 7 from a camel sampled in 1983 Obtaining a genome of a serum sample as old as ~ 40 years with repeated freeze-thaw cycles [40]
5a serum 2.46E+06 chronic HEV infection in a n immunocompromised patient with fatal outcome Compartment-specific subpopulation that contributed to patients’ clinical outcome? (Subpopulation with) ribavirin resistance mutations? Intra-host viral evolution?
High background of host nucleic acids.
unpublished/this study
5b duodenum 1.74E+06
5c liver 1.86E+06
5d medulla oblongata 5.62E+06
*

Due to the FFPE fixation this concentration is an estimate.